These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26689339)

  • 1. Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.
    Du Y; Kemper T; Qiu J; Jiang J
    Expert Rev Neurother; 2016; 16(2):123-30. PubMed ID: 26689339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.
    Jiang J; Yang MS; Quan Y; Gueorguieva P; Ganesh T; Dingledine R
    Neurobiol Dis; 2015 Apr; 76():126-136. PubMed ID: 25600211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus.
    Rojas A; Ganesh T; Lelutiu N; Gueorguieva P; Dingledine R
    Neuropharmacology; 2015 Jun; 93():15-27. PubMed ID: 25656476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy.
    Holtman L; van Vliet EA; van Schaik R; Queiroz CM; Aronica E; Gorter JA
    Epilepsy Res; 2009 Mar; 84(1):56-66. PubMed ID: 19186029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation.
    McElroy PB; Liang LP; Day BJ; Patel M
    Exp Neurol; 2017 Dec; 298(Pt A):13-22. PubMed ID: 28822838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cyclooxygenase-2 inhibitor parecoxib inhibits surgery-induced proinflammatory cytokine expression in the hippocampus in aged rats.
    Peng M; Wang YL; Wang FF; Chen C; Wang CY
    J Surg Res; 2012 Nov; 178(1):e1-8. PubMed ID: 22959208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection.
    Guerrero NA; Camacho M; Vila L; Íñiguez MA; Chillón-Marinas C; Cuervo H; Poveda C; Fresno M; Gironès N
    PLoS Negl Trop Dis; 2015; 9(8):e0004025. PubMed ID: 26305786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice.
    Fischborn SV; Soerensen J; Potschka H
    Epilepsy Res; 2010 Sep; 91(1):57-65. PubMed ID: 20655707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 Signaling: Alternative Target for Glioblastoma?
    Jiang J; Qiu J; Li Q; Shi Z
    Trends Cancer; 2017 Feb; 3(2):75-78. PubMed ID: 28718447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
    Okorji UP; Velagapudi R; El-Bakoush A; Fiebich BL; Olajide OA
    Mol Neurobiol; 2016 Nov; 53(9):6426-6443. PubMed ID: 26607631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
    Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
    Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation.
    Longo WE; Damore LJ; Mazuski JE; Smith GS; Panesar N; Kaminski DL
    Mediators Inflamm; 1998; 7(2):85-91. PubMed ID: 9836494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy.
    Radu BM; Epureanu FB; Radu M; Fabene PF; Bertini G
    Epilepsy Res; 2017 Mar; 131():15-27. PubMed ID: 28212985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isobutyrylshikonin inhibits lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in BV2 microglial cells by suppressing the PI3K/Akt-mediated nuclear transcription factor-κB pathway.
    Jayasooriya RG; Lee KT; Kang CH; Dilshara MG; Lee HJ; Choi YH; Choi IW; Kim GY
    Nutr Res; 2014 Dec; 34(12):1111-9. PubMed ID: 25454762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats.
    Ma L; Cui XL; Wang Y; Li XW; Yang F; Wei D; Jiang W
    Brain Res; 2012 Aug; 1469():103-13. PubMed ID: 22765917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.
    Henrotin Y; de Leval X; Mathy-Hartet M; Mouithys-Mickalad A; Deby-Dupont G; Dogné JM; Delarge J; Reginster JY
    Inflamm Res; 2001 Aug; 50(8):391-9. PubMed ID: 11556519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X purinoceptors as a link between hyperexcitability and neuroinflammation in status epilepticus.
    Henshall DC; Engel T
    Epilepsy Behav; 2015 Aug; 49():8-12. PubMed ID: 25843343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.
    Huang C; Chi XS; Li R; Hu X; Xu HX; Li JM; Zhou D
    J Mol Neurosci; 2017 Oct; 63(2):173-184. PubMed ID: 28856625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors.
    Yamazaki R; Kawai S; Matsuzaki T; Kaneda N; Hashimoto S; Yokokura T; Okamoto R; Koshino T; Mizushima Y
    Eur J Pharmacol; 1997 Jun; 329(2-3):181-7. PubMed ID: 9226412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.